Published in Infect Immun on March 01, 1982
Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci U S A (1988) 6.54
Diversity of Chlamydia trachomatis major outer membrane protein genes. J Bacteriol (1987) 6.16
Role of disulfide bonding in outer membrane structure and permeability in Chlamydia trachomatis. Infect Immun (1984) 5.00
Immunity to murine chlamydial genital infection. Infect Immun (2002) 4.64
Analysis of the human serological response to proteins of Chlamydia trachomatis. Infect Immun (1982) 4.57
Monoclonal antibody against a genus-specific antigen of Chlamydia species: location of the epitope on chlamydial lipopolysaccharide. Infect Immun (1984) 4.53
Sequence analysis of the major outer membrane protein gene from Chlamydia trachomatis serovar L2. J Bacteriol (1986) 4.13
High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis. J Exp Med (1988) 3.55
Disulfide-mediated interactions of the chlamydial major outer membrane protein: role in the differentiation of chlamydiae? J Bacteriol (1985) 3.23
Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein. Infect Immun (1982) 3.09
Protective monoclonal antibodies to Chlamydia trachomatis serovar- and serogroup-specific major outer membrane protein determinants. Infect Immun (1989) 2.87
Structural analysis of chlamydial major outer membrane proteins. Infect Immun (1982) 2.74
Phylogenetic analysis of the Chlamydia trachomatis major outer membrane protein and examination of potential pathogenic determinants. Infect Immun (1998) 2.27
Molecular cloning and expression of Chlamydia trachomatis major outer membrane protein antigens in Escherichia coli. Infect Immun (1985) 2.24
Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis. J Exp Med (1990) 2.13
Protective role of magnesium in the neutralization by antibodies of Chlamydia trachomatis infectivity. Infect Immun (1988) 2.11
Chlamydia trachomatis elementary bodies possess proteins which bind to eucaryotic cell membranes. J Bacteriol (1986) 2.08
Serovar determination of Chlamydia trachomatis isolates by using type-specific monoclonal antibodies. J Clin Microbiol (1986) 2.06
Monoclonal antibodies define genus-specific, species-specific, and cross-reactive epitopes of the chlamydial 60-kilodalton heat shock protein (hsp60): specific immunodetection and purification of chlamydial hsp60. Infect Immun (1992) 1.99
Diagnosis and assessment of trachoma. Clin Microbiol Rev (2004) 1.96
The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect Immun (1995) 1.94
Identification and properties of chlamydial polypeptides that bind eucaryotic cell surface components. J Bacteriol (1986) 1.93
Antigenic diversity of Chlamydia psittaci of mammalian origin determined by microimmunofluorescence. Infect Immun (1985) 1.84
Differences in outer membrane proteins of the lymphogranuloma venereum and trachoma biovars of Chlamydia trachomatis. Infect Immun (1985) 1.84
Chlamydial infections. West J Med (1990) 1.79
Tear and serum antibody response to Chlamydia trachomatis antigens during acute chlamydial conjunctivitis in monkeys as determined by immunoblotting. Infect Immun (1987) 1.76
Genome sequencing of recent clinical Chlamydia trachomatis strains identifies loci associated with tissue tropism and regions of apparent recombination. Infect Immun (2010) 1.71
Treponema phagedenis has at least two proteins residing together on its periplasmic flagella. J Bacteriol (1986) 1.69
Partial amino acid sequence and molecular cloning of the encoding gene for the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1985) 1.63
Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen. Proc Natl Acad Sci U S A (2006) 1.63
Typing of Chlamydia trachomatis strains from urine samples by amplification and sequencing the major outer membrane protein gene (omp1). Sex Transm Infect (2001) 1.62
Immunoassay for detecting Chlamydia trachomatis major outer membrane protein. J Clin Microbiol (1983) 1.61
Chlamydia trachomatis-induced production of interleukin-1 by human monocytes. Infect Immun (1989) 1.58
Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge. Infect Immun (1997) 1.51
Structural analysis of the variable major proteins of Borrelia hermsii. J Exp Med (1983) 1.50
Chemical and immunological analysis of the complex structure of Escherichia coli alpha-hemolysin. J Bacteriol (1985) 1.46
Functional and structural mapping of Chlamydia trachomatis species-specific major outer membrane protein epitopes by use of neutralizing monoclonal antibodies. Infect Immun (1991) 1.44
Immunogenicity of a chimeric peptide corresponding to T helper and B cell epitopes of the Chlamydia trachomatis major outer membrane protein. J Exp Med (1992) 1.41
Chemical and serological investigations on the genus-specific lipopolysaccharide epitope of Chlamydia. Proc Natl Acad Sci U S A (1987) 1.40
Comparison of sodium dodecyl sulfate-polyacrylamide gel electrophoresis profiles and antigenic relatedness among outer membrane proteins of 49 Brucella abortus strains. Infect Immun (1984) 1.40
Chemical, biological, and immunochemical properties of the Chlamydia psittaci lipopolysaccharide. Infect Immun (1986) 1.38
Strain and virulence diversity in the mouse pathogen Chlamydia muridarum. Infect Immun (2009) 1.36
Protection of sheep against Chlamydia psittaci infection with a subcellular vaccine containing the major outer membrane protein. Infect Immun (1990) 1.36
Immunochemical diversity of the major outer membrane protein of avian and mammalian Chlamydia psittaci. J Clin Microbiol (1988) 1.29
Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice. Infect Immun (1998) 1.29
The ompA gene in Chlamydia trachomatis differs in phylogeny and rate of evolution from other regions of the genome. Infect Immun (2006) 1.22
Binding of the glycan of the major outer membrane protein of Chlamydia trachomatis to HeLa cells. Infect Immun (1994) 1.22
Structural and functional analyses of the major outer membrane protein of Chlamydia trachomatis. J Bacteriol (2007) 1.21
Antigenic analysis of the major outer membrane protein of Chlamydia trachomatis with murine monoclonal antibodies. Infect Immun (1986) 1.20
Characterization of Chlamydia trachomatis omp1 genotypes detected in eye swab samples from remote Australian communities. J Clin Microbiol (2004) 1.18
Primary human T-cell responses to the major outer membrane protein of Chlamydia trachomatis. Immunology (1993) 1.13
Effect of proteolytic cleavage of surface-exposed proteins on infectivity of Chlamydia trachomatis. Infect Immun (1985) 1.11
Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants. Infect Immun (2001) 1.08
Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective. Infect Immun (2002) 1.06
Characterization of the murine antibody response to peptides representing the variable domains of the major outer membrane protein of Chlamydia pneumoniae. Infect Immun (1996) 1.06
Identification of immunodominant antigens of Chlamydia trachomatis using proteome microarrays. Vaccine (2009) 1.05
Identification of Chlamydia trachomatis outer membrane complex proteins by differential proteomics. J Bacteriol (2010) 1.05
Use of a reverse dot blot procedure to identify the presence of multiple serovars in Chlamydia trachomatis urogenital infection. J Clin Microbiol (2001) 1.03
Molecular cloning of the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1984) 1.02
Cloning and characterization of a Chlamydia trachomatis L3 DNA fragment that codes for an antigenic region of the major outer membrane protein and specifically hybridizes to the C- and C-related-complex serovars. Infect Immun (1989) 1.01
Phylogenetic analysis of Chlamydia trachomatis Tarp and correlation with clinical phenotype. Infect Immun (2010) 1.00
Antigenic specificity of serological response in Chlamydia trachomatis urethritis detected by immunoblotting. J Clin Pathol (1986) 1.00
Effect of serial passage in tissue culture on sequence of omp1 from Chlamydia trachomatis clinical isolates. J Clin Microbiol (1998) 1.00
DNA supercoiling-dependent gene regulation in Chlamydia. J Bacteriol (2008) 0.99
Characterization of a neutralizing monoclonal antibody directed at the lipopolysaccharide of Chlamydia pneumoniae. Infect Immun (1998) 0.97
Attachment of cell walls of Chlamydia psittaci to mouse fibroblasts (L cells). Infect Immun (1982) 0.95
Characterization of a neutralizing monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars. Infect Immun (1993) 0.95
Evaluation of a novel PCR-based assay for detection and identification of Chlamydia trachomatis serovars in cervical specimens. J Clin Microbiol (2007) 0.95
Antigenic and immunogenic properties of recombinants from Salmonella typhimurium and Salmonella minnesota rough mutants expressing in their lipopolysaccharide a genus-specific chlamydial epitope. Infect Immun (1987) 0.92
Identification of immunodominant antigens by probing a whole Chlamydia trachomatis open reading frame proteome microarray using sera from immunized mice. Infect Immun (2010) 0.90
Characterization of the humoral response induced by a peptide corresponding to variable domain IV of the major outer membrane protein of Chlamydia trachomatis serovar E. Infect Immun (1992) 0.90
Proteomic identification of immunodominant chlamydial antigens in a mouse model. J Proteomics (2012) 0.84
Mutagenesis and functional reconstitution of chlamydial major outer membrane proteins: VS4 domains are not required for pore formation but modify channel function. Infect Immun (2001) 0.84
Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model. Vaccine (2011) 0.84
Chlamydia trachomatis from Australian Aboriginal people with trachoma are polyphyletic composed of multiple distinctive lineages. Nat Commun (2016) 0.83
Chlamydophila felis CF0218 is a novel TMH family protein with potential as a diagnostic antigen for diagnosis of C. felis infection. Clin Vaccine Immunol (2008) 0.77
Immunization with a peptide corresponding to chlamydial heat shock protein 60 increases the humoral immune response in C3H mice to a peptide representing variable domain 4 of the major outer membrane protein of Chlamydia trachomatis. Clin Diagn Lab Immunol (1999) 0.77
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1981) 18.13
New knowledge of chlamydiae and the diseases they cause. J Infect Dis (1975) 9.35
A manual of quantitative immunoelectrophoresis. Methods and applications. 1. General remarks on principles, equipment, reagents and procedures. Scand J Immunol Suppl (1973) 4.07
Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. I. Antigenic heterogeneity between C. trachomatis and C. psittaci. J Immunol (1975) 3.41
Lack of deoxyribonucleic acid homology between species of the genus Chlamydia. J Bacteriol (1968) 3.36
Immunochemical studies of thylakoid membrane polypeptides from spinach and Chlamydomonas reinhardtii. A modified procedure for crossed immunoelectrophoresis of dodecyl sulfate.protein complexes. J Biol Chem (1979) 3.14
Identification of a major envelope protein in Chlamydia spp. J Bacteriol (1981) 3.08
Polypeptide composition of Chlamydia trachomatis. J Gen Microbiol (1981) 2.43
Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. II. A trachoma-LGV-specific antigen. J Immunol (1975) 1.73
Isolation and purification of a type-specific antigen from Chlamydia trachomatis propagated in cell culture utilizing molecular shift chromatography. J Immunol (1980) 1.41
Nonspecific precipitation of serum proteins by sodium lauryl sulfate in agar diffusion and immunoelectrophoresis. Appl Microbiol (1971) 1.37
Purification of a Chlamydia trachomatis-specific antigen by immunoadsorption with monospecific antibody. J Immunol (1977) 1.22
Isolation of a type-specific antigen from Chlamydia trachomatis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Immunol (1979) 1.07
Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1981) 18.13
Chlamydial infections (third of three parts). N Engl J Med (1978) 9.21
Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet (1995) 7.46
Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci U S A (1988) 6.54
Chlamydial infections (first of three parts). N Engl J Med (1978) 5.79
Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars. Infect Immun (1989) 5.75
Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J Immunol (1987) 5.64
Chlamydiae. Annu Rev Microbiol (1980) 5.47
Role of disulfide bonding in outer membrane structure and permeability in Chlamydia trachomatis. Infect Immun (1984) 5.00
Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs. J Clin Microbiol (2001) 4.92
Are chlamydial infections the most prevalent venereal disease? JAMA (1975) 4.79
Monoclonal antibody against a genus-specific antigen of Chlamydia species: location of the epitope on chlamydial lipopolysaccharide. Infect Immun (1984) 4.53
Severe endemic trachoma in Tunisia. Br J Ophthalmol (1976) 4.35
Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid. J Bacteriol (1982) 4.33
Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med (1989) 4.25
Chlamydial infections. Annu Rev Med (1981) 3.94
Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. J Infect Dis (1994) 3.93
Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J Immunol (1997) 3.66
Screening for chlamydial infections in women attending family planning clinics. West J Med (1983) 3.51
Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol (2003) 3.50
CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect Immun (1995) 3.45
Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J Clin Microbiol (2000) 3.44
Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. I. Antigenic heterogeneity between C. trachomatis and C. psittaci. J Immunol (1975) 3.41
Chlamydial infections (second of three parts). N Engl J Med (1978) 3.40
Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis (1992) 3.30
Failure of serology in diagnosing chlamydial infections of the female genital tract. J Clin Microbiol (1979) 3.27
Disulfide-mediated interactions of the chlamydial major outer membrane protein: role in the differentiation of chlamydiae? J Bacteriol (1985) 3.23
Pneumonia due to Chlamydia trachomatis in the immunocompromised (nude) mouse. J Infect Dis (1981) 3.19
Chlamydia trachomatis-host cell interactions: role of the chlamydial major outer membrane protein as an adhesin. Infect Immun (1990) 3.13
Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein. Infect Immun (1982) 3.09
The 7.5-kb plasmid present in Chlamydia trachomatis is not essential for the growth of this microorganism. Plasmid (1990) 3.08
Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein. J Exp Med (1989) 3.03
Prevalence of urethral Chlamydia trachomatis and Neisseria gonorrhoeae among asymptomatic, sexually active adolescent boys. J Infect Dis (1987) 3.02
The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med (1994) 2.92
The association between Chlamydia trachomatis and ectopic pregnancy. A matched-pair, case-control study. JAMA (1990) 2.91
Urinary leukocyte esterase screening test for asymptomatic chlamydial and gonococcal infections in males. JAMA (1989) 2.87
Protective monoclonal antibodies to Chlamydia trachomatis serovar- and serogroup-specific major outer membrane protein determinants. Infect Immun (1989) 2.87
Immunodiagnosis of sexually transmitted disease. Yale J Biol Med (1986) 2.82
The venereal nature of inclusion conjunctivitis. Am J Epidemiol (1967) 2.80
Comparison of monoclonal antibody staining and culture in diagnosing cervical chlamydial infection. J Clin Microbiol (1986) 2.80
Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae. J Clin Microbiol (2000) 2.80
Nonculture tests for genital tract chlamydial infection. What does the package insert mean, and will it mean the same thing tomorrow? Sex Transm Dis (1992) 2.80
Prospective study of chlamydial infection in neonates. Lancet (1979) 2.80
The role of antibody in host defense against the agent of mouse pneumonitis. J Infect Dis (1982) 2.78
Lymphogranuloma venereum. II. Characterization of some recently isolated strains. J Bacteriol (1969) 2.78
Structural analysis of chlamydial major outer membrane proteins. Infect Immun (1982) 2.74
Rapid diagnosis of sexually transmitted diseases--speed has a price. Diagn Microbiol Infect Dis (1986) 2.69
Latrine ownership as a protective factor in inflammatory trachoma in Egypt. Br J Ophthalmol (1991) 2.67
Topical tetracycline and rifampicin therapy of endemic trachoma in Tunisia. Am J Ophthalmol (1975) 2.66
Confirmatory assay increases specificity of the chlamydiazyme test for Chlamydia trachomatis infection of the cervix. J Clin Microbiol (1990) 2.65
Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect Immun (1995) 2.55
A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. Infect Immun (1990) 2.55
Relative resistance to erythromycin in Chlamydia trachomatis. Antimicrob Agents Chemother (1980) 2.55
Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect Immun (2000) 2.53
Infection with Chlamydia pneumoniae in Brooklyn. J Infect Dis (1991) 2.35
Pathogenesis of trachoma: the stimulus for inflammation. J Immunol (1987) 2.34
Cloning and sequence analysis of the major outer membrane protein genes of two Chlamydia psittaci strains. Infect Immun (1989) 2.32
Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice. Infect Immun (1988) 2.30
Cellular immunity to the mouse pneumonitis agent. J Infect Dis (1984) 2.28
Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect Immun (1997) 2.26
Ocular delayed hypersensitivity: a pathogenetic mechanism of chlamydial-conjunctivitis in guinea pigs. Proc Natl Acad Sci U S A (1986) 2.24
Comparison of the major outer membrane protein variant sequence regions of B/Ba isolates: a molecular epidemiologic approach to Chlamydia trachomatis infections. J Infect Dis (1992) 2.21
Inhibition of antichlamydial IgM antibody by IgG antibody in immunofluorescence tests. J Immunol (1972) 2.20
Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J Exp Med (1998) 2.19
Isolation of bedsoniae from the joints of patients with Reiter's syndrome. Proc Soc Exp Biol Med (1966) 2.17
An animal model of trachoma II. The importance of repeated reinfection. Invest Ophthalmol Vis Sci (1982) 2.16
Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis. J Exp Med (1990) 2.13
Major outer membrane protein variants of Chlamydia trachomatis are associated with severe upper genital tract infections and histopathology in San Francisco. J Infect Dis (1995) 2.12
Why we need a program for the control of Chlamydia trachomatis. N Engl J Med (1989) 2.12
Evaluation of urine-based screening strategies to detect Chlamydia trachomatis among sexually active asymptomatic young males. JAMA (1993) 2.12
Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis (1996) 2.12
Chlamydia trachomatis: important relationships to race, contraception, lower genital tract infection, and Papanicolaou smear. J Pediatr (1984) 2.11
Chlamydia trachomatis infection and pregnancy outcome. Am J Obstet Gynecol (1987) 2.11
Plaque formation by Chlamydia in L cells. Infect Immun (1970) 2.09
A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity. Chest (1993) 2.09
The intracellular life of Chlamydia. Curr Top Microbiol Immunol (1988) 2.09
Multiple-antigen slide test for detection of immunoglobulin M antibodies in newborn and infant sera by immunofluorescence. J Clin Microbiol (1981) 2.07
Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA (1986) 2.06
Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition. J Immunol (1999) 2.06
NIMH/APPC workgroup on behavioral and biological outcomes in HIV/STD prevention studies: a position statement. Sex Transm Dis (2000) 2.05
Enzyme immunoassay for diagnosis of gonorrhea. J Clin Microbiol (1984) 2.03
Differential human serologic response to two 60,000 molecular weight Chlamydia trachomatis antigens. J Infect Dis (1990) 2.02
Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol (2000) 2.02
Chlamydia trachomatis-induced salpingitis in mice. J Infect Dis (1983) 1.99
Pneumonitis following inclusion blennorrhea. J Pediatr (1975) 1.95
Screening for Chlamydia trachomatis and Neisseria gonorrhoeae in adolescent males: value of first-catch urine examination. Lancet (1984) 1.91
Is the routine pelvic examination needed with the advent of urine-based screening for sexually transmitted diseases? Arch Pediatr Adolesc Med (1999) 1.91
Differential effect of trypsin on infectivity of Chlamydia trachomatis: loss of infectivity requires cleavage of major outer membrane protein variable domains II and IV. Infect Immun (1988) 1.89
Enhancement of Chlamydia trachomatis infectious progeny by cultivation of HeLa 229 cells treated with DEAE-dextran and cycloheximide. J Clin Microbiol (1984) 1.87
A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells. Proc Natl Acad Sci U S A (1996) 1.87
Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis (1995) 1.86
Expression of the chlamydial genus-specific lipopolysaccharide epitope in Escherichia coli. Science (1985) 1.85
Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc Natl Acad Sci U S A (2001) 1.85
Cytobrush in collection of cervical specimens for detection of Chlamydia trachomatis. J Clin Microbiol (1989) 1.84
Amoxicillin therapy for Chlamydia trachomatis in pregnancy. Obstet Gynecol (1990) 1.83
Microbiology of the lower genital tract in postmenarchal adolescent girls: differences by sexual activity, contraception, and presence of nonspecific vaginitis. J Pediatr (1985) 1.81
Evaluation of laboratory methods for detecting acute TRIC agent infection. Am J Ophthalmol (1970) 1.77